NO20006198L - Methods for inhibiting TEF-3 activity - Google Patents

Methods for inhibiting TEF-3 activity

Info

Publication number
NO20006198L
NO20006198L NO20006198A NO20006198A NO20006198L NO 20006198 L NO20006198 L NO 20006198L NO 20006198 A NO20006198 A NO 20006198A NO 20006198 A NO20006198 A NO 20006198A NO 20006198 L NO20006198 L NO 20006198L
Authority
NO
Norway
Prior art keywords
tef
inhibiting
activity
methods
inhibiting tef
Prior art date
Application number
NO20006198A
Other languages
Norwegian (no)
Other versions
NO20006198D0 (en
Inventor
Michael Howard Tindal
Richard Lee Wang
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO20006198D0 publication Critical patent/NO20006198D0/en
Publication of NO20006198L publication Critical patent/NO20006198L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
NO20006198A 1998-06-30 2000-12-06 Methods for inhibiting TEF-3 activity NO20006198L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9131898P 1998-06-30 1998-06-30
PCT/US1999/014829 WO2000000161A2 (en) 1998-06-30 1999-06-30 Methods for identification of tef-3 interacting factors

Publications (2)

Publication Number Publication Date
NO20006198D0 NO20006198D0 (en) 2000-12-06
NO20006198L true NO20006198L (en) 2001-02-28

Family

ID=22227169

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006198A NO20006198L (en) 1998-06-30 2000-12-06 Methods for inhibiting TEF-3 activity

Country Status (7)

Country Link
EP (1) EP1089794A2 (en)
JP (1) JP2002519008A (en)
AU (1) AU5086699A (en)
CA (1) CA2332121A1 (en)
IL (1) IL140058A0 (en)
NO (1) NO20006198L (en)
WO (1) WO2000000161A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003001906A1 (en) * 2001-06-27 2003-01-09 Takeda Chemical Industries, Ltd. Method of constructing joint disease model animal

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824794A (en) * 1994-12-23 1998-10-20 Syntex (U.S.A.) Inc. Human stromelysin-1 promoter
US5569588A (en) * 1995-08-09 1996-10-29 The Regents Of The University Of California Methods for drug screening
EP0935753A4 (en) * 1996-10-31 1999-12-08 Merck & Co Inc Assay and cell line for the identification of growth hormone mimetics
AU6015098A (en) * 1997-02-24 1998-09-09 Cornell Research Foundation Inc. Method of screening agents as candidates for drugs or sources of drugs

Also Published As

Publication number Publication date
JP2002519008A (en) 2002-07-02
EP1089794A2 (en) 2001-04-11
AU5086699A (en) 2000-01-17
WO2000000161A2 (en) 2000-01-06
NO20006198D0 (en) 2000-12-06
IL140058A0 (en) 2002-02-10
CA2332121A1 (en) 2000-01-06
WO2000000161A3 (en) 2001-01-04

Similar Documents

Publication Publication Date Title
LTC1124961I2 (en) THROMBOPOETINE COMPOUNDS
ATE229954T1 (en) BETACARBOLINE COMPOUNDS
ID28266A (en) AMIDIN COMPOUNDS
ID29066A (en) FENILGLISINA DOWN
ID27423A (en) KUINOLIN DOWN
NO20011745L (en) compounds
ID23234A (en) BENZOSULFONA DOWN
ID27484A (en) ADENOSINA DOWN
DE69917184D1 (en) recorder
ID27547A (en) KUINOLIN DOWN
NO20005006L (en) Calcilitic compounds
DE69929547D1 (en) recorder
DE69933629D1 (en) RECORDER
ATE252547T1 (en) MATRIXMETALLOPROTEINASE INHIBITORS
NO20006662L (en) Fluorfenylresin compounds
ID23196A (en) DESCRIPTION FOR LAMPUFLOURESEN
FI980759A0 (en) Taetningskonstruktion Foer suglaodan i en sugvals
ID28356A (en) DOWN TIAZOLA
FI982678L (en) Recording
ID28433A (en) PROPENIL SEFALOSPORIN DEPOSITS
FI980550L (en) Bed
NO20006198D0 (en) Methods for inhibiting TEF-3 activity
NO980270L (en) Trekka scheme
NO20006314D0 (en) Prenyltransferase inhibitors
DE69941286D1 (en) FOR ROLLEDS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application